1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with nco 700 in 1 studies
Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (nco 700) | Trials (nco 700) | Recent Studies (post-2010) (nco 700) |
---|---|---|---|---|---|
9,156 | 187 | 552 | 15 | 0 | 0 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Iizuka, K; Kawaguchi, H; Takano, H; Yasuda, H | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and nco 700
Article | Year |
---|---|
Platelet aggregation induced by platelet-activating factor is suppressed by cystine protease inhibitor.
Topics: Animals; Blood Platelets; Calpain; Cathepsin B; In Vitro Techniques; Indomethacin; Piperazines; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Protease Inhibitors; Rabbits; Serotonin | 1991 |